Inotuzumab ozogamicin (INO) clinical trials

International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)

This study is looking at new ways to treat a type of childhood leukaemia called B-Cell Acute Lymphoblastic Leukaemia (ALL) when it comes back. It aims to use kinder, more targeted treatments instead of strong chemotherapy.